Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		134,046,926
Beginning balance at Dec. 31, 2021	$ 1,189,289	$ 13	$ 1,852,071	$ (583)	$ (662,212)
Exercise of stock options (in shares)		697,998
Exercise of stock options	6,795		6,795
Stock-based compensation	39,375		39,375
Issuance of common stock upon settlement of restricted stock units (in shares)		706,663
Other comprehensive income	345			345
Net loss	(71,419)				(71,419)
Ending balance (in shares) at Mar. 31, 2022		135,451,587
Ending balance at Mar. 31, 2022	1,164,385	$ 13	1,898,241	(238)	(733,631)
Beginning balance (in shares) at Dec. 31, 2022		139,159,534
Beginning balance at Dec. 31, 2022	$ 1,116,780	$ 14	2,068,225	(2,316)	(949,143)
Exercise of stock options (in shares)	272,032	272,032
Exercise of stock options	$ 3,651		3,651
Stock-based compensation	47,060		47,060
Issuance of common stock upon settlement of restricted stock units (in shares)		940,122
Other comprehensive income	308			308
Net loss	(63,447)				(63,447)
Ending balance (in shares) at Mar. 31, 2023		140,371,688
Ending balance at Mar. 31, 2023	$ 1,104,352	$ 14	$ 2,118,936	$ (2,008)	$ (1,012,590)